PhRMA

MARCH 28, 2023

It’s that time of year again when the president releases his budget and questions arise about the solvency of the Medicare trust fund and Medicare spending more generally. Too often, critics point to spending on Medicare Part B medicines as a key driver of Medicare spending, but the data tells a different story. For example, next month the Medicare Payment Advisory Comission plans to vote on policy proposals that ignore the facts around Medicare Part B, and could harm patient access to both curr

234

234

Drug Topics

MARCH 28, 2023

According to a recent study, the diabetes medication semaglutide is more effective as a 25 mg or 50 mg dose on its own, rather than a 14 mg add-on dose with other medications.

181

181

PhRMA

MARCH 28, 2023

Chronic diseases like Alzheimer’s disease, diabetes and kidney disease disproportionately affect older adults. In the United States, nearly 95% of older adults have at least one chronic condition and almost 80% have two or more. Chronic diseases can often limit an older adult’s ability to work, perform daily activities, cause them to lose their independence and lead to the need for long-term care.

226

226

Drug Topics

MARCH 28, 2023

The drug, called Leniolisib, is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

FDA 187

FDA 187

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MARCH 28, 2023

A panel of experts that advises the World Health Organization on vaccine use suggested Tuesday that countries no longer need to consider offering additional Covid-19 boosters to people at medium or low risk of becoming seriously ill if they contract the SARS-CoV-2 virus. The Strategic Advisory Group of Experts on Immunization — which is known as the SAGE — said some countries may continue to offer boosters to people at medium and low risk, but those decisions should be made ba

Vaccines 131

Vaccines Immunization 131

Drug Topics

MARCH 28, 2023

COVID-19 misinformation is common. A study presented at the annual APhA meeting examined how new pharmacy practitioners responded to misinformation and tried to minimize its spread.

98

98

Drug Topics

MARCH 28, 2023

The risk of developing breast cancer was greater in women who are currently using or recently used progestogen-only contraceptives, a recent study showed.

98

98

STAT

MARCH 28, 2023

As the U.S. drug crisis has accelerated, the pharmaceutical industry has jumped into action — particularly when it comes to naloxone, the drug used to reverse opioid overdoses. In recent years, companies have introduced a dizzying array of ambitious new naloxone products. They include a mechanized injector that gives robotic voice commands , a prefilled syringe pen, an ultra-high-dose nasal spray, and an autoinjector that the Pentagon has purchased for use in the event of a terrorist atta

127

127

Pharmaceutical Technology

MARCH 28, 2023

Following on from its Covid-19 vaccine programmes, BioNTech has set its sights on a range of infectious diseases for vaccine development. In its FY 2022 report, BioNTech has identified herpes simplex virus (HSV), malaria, and shingles as disease targets. The company saw major successes with its Covid-19 vaccine, developed in collaboration with Pfizer.

Vaccines 110

Vaccines 110

Fierce Healthcare

MARCH 28, 2023

ViVE 2023: Amazon Pharmacy integrates coupons in latest bid to target affordability of branded drugs hlandi Tue, 03/28/2023 - 15:24

119

119

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Store News

MARCH 28, 2023

From March 31-April 9, customers can donate their free ham certificates in-store at the register or 400 CHOICE points online, for which Giant will donate $10 to a local food bank.

98

98

PharmaVoice

MARCH 28, 2023

The Supreme Court will now decide whether Amgen can protect Repatha as a whole class of drugs or whether Sanofi’s rival product Praluent can retain a place in the market.

98

98

Fierce Healthcare

MARCH 28, 2023

'Podnosis': Insight on the Ohio train derailment class-action lawsuit, and how data analytics can improve social risk factor identification tcarey Tue, 03/28/2023 - 14:07

98

98

The Checkup by Singlecare

MARCH 28, 2023

If you’re pregnant, and feeling faint, lightheaded, or a little off balance, low blood pressure might be to blame. Although we usually think of high blood pressure as a complication of pregnancy, low blood pressure during pregnancy is quite common as well—especially in the first 24 weeks of pregnancy. Thankfully, experiencing low blood pressure while pregnant usually doesn’t cause severe complications and can be treated with at-home remedies.

Hospitals 97

Hospitals 97

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

MARCH 28, 2023

At our pediatric clinic, we recently saw a child whose mother lost her job during the pandemic working as a caterer. The mother struggled to put food on the table after the precipitous loss of income. After the family enrolled in SNAP, we could literally measure how that policy benefited our young patient. After teetering close to severe malnutrition, she returned to a healthy weight.

96

96

Drug Topics

MARCH 28, 2023

Two posters presented at APhA in Phoenix examined the efficacy of the Omnipod® 5 Automated Insulin Delivery System.

98

98

Fierce Healthcare

MARCH 28, 2023

Carrot Fertility expands benefits with hormone replacement therapy coverage agliadkovskaya Tue, 03/28/2023 - 14:43

120

120

European Pharmaceutical Review

MARCH 28, 2023

The European Commission (EC) has approved Sotyktu (deucravacitinib), a first-in-class, allosteric tyrosine kinase 2 (TYK2) inhibitor for adults with moderate-to-severe plaque psoriasis. The oral treatment is indicated for patients who are candidates for systemic therapy. Bristol Myers Squibb’s TYK2 inhibitor Sotyktu is the first oral therapy with a new mechanism of action approved in nearly 10 years for moderate-to-severe plaque psoriasis” Sotyktu is the first oral therapy with a new

Dosage 94

Dosage Immunization 94

Fierce Healthcare

MARCH 28, 2023

ViVe 2023: CancerX co-hosts Moffitt Cancer Center, Digital Medicine Society, unveil 'Moonshot' digital health effort hlandi Tue, 03/28/2023 - 07:36

104

104

Pharmaceutical Technology

MARCH 28, 2023

Vertex Pharmaceuticals has signed a new non-exclusive licensing agreement with CRISPR Therapeutics to expedite the development of its hypoimmune cell therapies to treat type 1 diabetes (T1D). Under the terms of the deal, the company will receive non-exclusive rights to CRISPR/Cas9, a gene-editing technology of CRISPR Therapeutics, for the development of potentially curative T1D cell therapies.

Communication 94

Communication 94

PioneerRx

MARCH 28, 2023

Your hands are full as an independent pharmacist. Whether it’s helping patients, filling prescriptions, administering vaccinations, or managing your pharmacy’s.

Independent Pharmacies 98

Independent Pharmacies Vaccines 98

STAT

MARCH 28, 2023

Top of the morning to you. Steely gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us.

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies 92

Drug Store News

MARCH 28, 2023

Advertisers can now reach DG’s more than 90 million unique customer profiles across the Meta ecosystem via Facebook and Instagram news feeds, stories and reels.

97

97

Drug Topics

MARCH 28, 2023

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

FDA 98

FDA 98

STAT

MARCH 28, 2023

The tech-forward insurer Oscar Health has tapped former Aetna CEO Mark Bertolini to be its new chief executive, a move to jump-start the business as it seeks to win new customers and become profitable. Bertolini, 66, is a progressive thinker in the use of technology to deliver health services and has already been advising Oscar for the past 18 months.

Insurance 88

Insurance 88

Fierce Healthcare

MARCH 28, 2023

Hospitals feel congressional heat over compliance with price transparency rule rking Tue, 03/28/2023 - 17:11

Hospitals 104

Hospitals 104

STAT

MARCH 28, 2023

Intra-Cellular Therapies, maker of an approved treatment for schizophrenia and bipolar depression, announced positive results from a new clinical trial on Tuesday that could potentially expand use of its drug to other types of mood disorders. Sales of the Intra-Cellular drug, called Caplyta, tripled last year to $249 million. The new study results, while not definitive, bolster confidence that the drug could also prove effective for people with major depressive disorder and so-called mixed featu

87

87

Fierce Pharma

MARCH 28, 2023

FDA committee will hear Perrigo's OTC bid for birth control med Opill in May kdunleavy Tue, 03/28/2023 - 14:47

FDA 101

FDA 101

STAT

MARCH 28, 2023

Viking Therapeutics, a small biotechnology company, said Tuesday that its experimental medicine led patients to lose as much as 6% more body weight than those on placebo in just six days. The results are from a small, early Phase 1 study, and the drug will require much more research in studies of thousands of patients in order to establish its efficacy and safety.

85

85

Drug Store News

MARCH 28, 2023

CeraVe took on New Orleans with some of social media’s biggest dermatologists to launch its new #21DaysofSPF challenge.

96

96

European Pharmaceutical Review

MARCH 28, 2023

Eli Lilly and Company will double its investment to nearly $1 billion at its new biologics drug manufacturing facility, in Raheen, Limerick, stated Ireland’s Industrial Development Agency (IDA). This follows the company’s announced $500 million manufacturing investment in January 2022. The new 500,000 square foot facility, currently in construction, will use state-of-the-art biologics manufacturing technology to produce active ingredients for therapies.

Pharmaceutical Companies 76

Pharmaceutical Companies Pharmaceutical Companies 76

Pharmafile

MARCH 28, 2023

PMGroup Worldwide Ltd (PMGroup) has announced the launch of its new recruitment platform, PharmaRole.com, designed to make it as simple as possible for applicants to find and apply for jobs in the pharmaceutical and life sciences industry. The mobile-friendly platform boasts an easy sign-up process, with job seekers given the option to log in using their LinkedIn profiles for a quick set-up.

72

72

Drug Store News

MARCH 28, 2023

WBA's U.S. healthcare segment's businesses grew sales at a combined rate of 30% in the quarter.

98

98

Fierce Pharma

MARCH 28, 2023

After Twist and Ginkgo campaigns, Scorpion Capital aims stinger at Harmony Biosciences fkansteiner Tue, 03/28/2023 - 11:11

85

85